Business Practice

Cybersecurity is an aspect of business infrastructure that needs to be taken seriously.

Pharma’s 2022 growth forecast has been reduced for the first time in a decade.

EMA relocation, a price-fixing scandal, and FDA warning letters… What's new for pharma in business?

The EFPIA highlights the risks of disrupting UK–EU medicine supply chains.

The FDA has approved a pill with the ability to track patient compliance.

Researchers find significant variation in regulation of pharmaceutical market systems in the developing world

How harmonization and international standards bodies bind trade and regulation in the pharma industry

In certain areas, there is significant disharmony across the ICH regions…

Margaret Hamburg, former FDA Commissioner, has led the agency through a period of increasing globalization.

Globalization has created an industrywide demand for regulatory harmonization. But who benefits?